The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs
Authors:
- Nicolas MartelliNMNicolas Martelli
- Malik BerhouneMBMalik Berhoune
- Marie-Laure MaestroniMMMarie-Laure Maestroni
- Laurent HavardLHLaurent Havard
- Patrice PrognonPPPatrice Prognon
Open Access
- 1 February 2009
- journal article
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 21 (1) , 44-50
Abstract
Objective To apply the Hazard Analysis and Critical Control Points method to the preparation of anti-cancer drugs. To identify critical control points in our cancer chemotherapy process and to propose control measures and corrective actions to manage these processes.Keywords
This publication has 20 references indexed in Scilit:
- ASHP Guidelines on Handling Hazardous DrugsAmerican Journal of Health-System Pharmacy, 2006
- Reconstitution des chimiothérapies anticancéreusesAnnales Pharmaceutiques Françaises, 2006
- Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy processInternational Journal for Quality in Health Care, 2005
- Environmental Contamination with Cytotoxic Drugs in Healthcare Using Positive Air Pressure IsolatorsAnnals of Occupational Hygiene, 2005
- Exposure to Antineoplastic Drugs in Two UK Hospital Pharmacy UnitsAnnals of Occupational Hygiene, 2005
- Patterns of Dermal Exposure to Hazardous Substances in European Union WorkplacesAnnals of Occupational Hygiene, 2004
- The Application of HACCP in Clinical EngineeringJournal of Clinical Engineering, 2003
- Drugs Hazardous to Healthcare WorkersDrug Safety, 1999
- Exposure of Pharmacy Technicians to Antineoplastic Agents: Reevaluation after Additional Protective MeasuresArchives of Environmental Health: An International Journal, 1997
- Monitoring of occupational exposure to cytostatic anticancer agentsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1996